Track: Heart Failure and Advanced Cardiac Therapies
Heart Failure and Advanced Cardiac Therapies remains an important area in modern cardiovascular medicine due to the growing need for evidence-based diagnosis, advanced therapeutic strategies, precision healthcare, and improved patient outcomes. This session provides a scientific platform for clinicians, researchers, healthcare professionals, and academicians to discuss recent clinical developments, emerging technologies, translational research, and future directions associated with heart failure and advanced cardiac therapies. The session will feature expert presentations, clinical discussions, case-based learning, and interdisciplinary perspectives focused on improving cardiovascular healthcare delivery and advancing global cardiology research.
Key Discussion Areas:
- Quadruple therapy optimisation and sequencing in HFrEF
- SGLT2 inhibitors across the full heart failure spectrum including HFpEF
- ATTR-CM: tafamidis, acoramidis, and RNA-silencing therapies
- Mavacamten and next-generation myosin inhibitors in obstructive HCM
- Genetic testing and cascade screening in inherited cardiomyopathies
- Remote pulmonary artery pressure monitoring and CardioMEMS outcomes
- Durable LVAD therapy vs. cardiac transplantation: decision frameworks
- Cardiac gene therapy: AAV-based and base-editing approaches in DCM
Why Attend This Session?
Heart failure specialists, general cardiologists, cardiac surgeons, and advanced practice providers will gain practical frameworks for phenotype-guided therapy selection, guideline-directed medical therapy titration, and up-to-date knowledge on pivotal trial results reshaping cardiomyopathy management.
Related Topics
- Cardiac Transplantation & Mechanical Circulatory Support
- Cardiac Genetics & Inherited Disorders
- AI in Cardiology
- Cardiac Imaging & Advanced Diagnostics
- Preventive Cardiology
Frequently Asked Questions
1.What is the importance of heart failure and advanced cardiac therapies in cardiovascular medicine?
Heart Failure and Advanced Cardiac Therapies plays a significant role in improving diagnosis, treatment strategies, patient outcomes, and clinical decision-making in modern cardiology.
2.What are the latest trends in heart failure and advanced cardiac therapies?
Recent trends include precision medicine, AI-assisted diagnostics, minimally invasive therapies, digital healthcare technologies, and personalized patient management.
Scientific Highlights
- Preventive Cardiology and Cardiovascular Risk Reduction
- Heart Failure and Advanced Cardiac Therapies
- Interventional Cardiology and Structural Heart Disease
- Cardiac Electrophysiology and Arrhythmia Management
- Acute Coronary Syndromes
- Cardiovascular Imaging and Multimodality Diagnostics
- Cardiomyopathies: Genetics, Phenotyping, and Treatment
- Cardio Oncology
- Cardiometabolic Disease, Lipidology, and Atherosclerosis
- Hypertension and Renal Cardiovascular Interactions
- Digital Health, AI, and the Future of Cardiology
- Pediatric and Congenital Cardiology
- Vascular Medicine and Aortic Diseases
- Women's Cardiovascular Health and Sports Cardiology
- Precision Medicine, Genomics, and Regenerative Cardiology
- Cardiovascular and Cardiothoracic Surgery
- Cardiovascular Case Studies and Clinical Insights
- Emergency and Critical Cardiac Care
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Conference Enquiry - Kristina Pierce
kristinapierce@scientexconferences.com
General Enquiry
contact@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
cardiacsurgery@scientexevents.org
Our Social Presence
Call us at
USA : (+1) 272 374 1068